Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL)
Akash Shukla(Lokmanya Tilak Municipal General Hospital and Lokmanya Tilak Municipal Medical College), Shiv Kumar Sarin(Institute of Liver and Biliary Sciences), Amar Mukund(Institute of Liver and Biliary Sciences), Xingshun Qi(General Hospital of Shenyang Military Region), Yasuhiko Sugawara(Kumamoto University), Mamun Al Meshtab(Kurume University), Roongruedee Chaiteeraki(Chulalongkorn University), Ian Homer Y.(St. Luke's Medical Center), Valérie Paradis(Inserm), Guohong Han(Medical Center Hospital), Suprabhat Giri(Institute of Medical Sciences), Hemant Deshmukh(King Edward Memorial Hospital and Seth G.S. Medical College), Zaigham Abbas(Ziauddin Hospital), Cosmas Rinaldi Adithya Lesmana(University of Indonesia), Ananta Shreshtha, CE Eapen, Sundeep Punamiya(Tan Tock Seng Hospital), Sombat Treeprasertsuk(Thai Red Cross Society), Masayoshi Kage(Junshin Gakuen University), Chhagan Bihari(Institute of Liver and Biliary Sciences)
Cited by 97
Related Papers
Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
|Hepatology International|2017|2.2k
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
|Journal of Hepatology|2003|1.6k
Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites
|Journal of Hepatology|2015|864
Neither Multiple Tumors Nor Portal Hypertension Are Surgical Contraindications for Hepatocellular Carcinoma
|Gastroenterology|2008|765
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
|The Lancet. Gastroenterology & hepatology|2022|664